Cargando…
Advances in Targeted Immunotherapy for Hepatobiliary Cancers
Cancer of the hepatobiliary system can be divided into primary liver cancer and biliary tract cancer (BTC), which includes hepatocellular carcinoma (HCC), cholangiocarcinoma (CCA), and gallbladder cancer (GBC). These aggressive cancers often present at an advanced stage or among patients with poorly...
Autores principales: | Ruff, Samantha M., Shannon, Alexander H., Pawlik, Timothy M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698563/ https://www.ncbi.nlm.nih.gov/pubmed/36430440 http://dx.doi.org/10.3390/ijms232213961 |
Ejemplares similares
-
The State of Immunotherapy in Hepatobiliary Cancers
por: Ilyas, Farhan Z., et al.
Publicado: (2021) -
The Role of Targeted Therapy in the Multi-Disciplinary Approach to Colorectal Liver Metastasis
por: Ruff, Samantha M., et al.
Publicado: (2023) -
Hereditary Pancreatic and Hepatobiliary Cancers
por: Haddad, Ashraf, et al.
Publicado: (2011) -
A Review of Translational Research for Targeted Therapy for Metastatic Colorectal Cancer
por: Ruff, Samantha M., et al.
Publicado: (2023) -
Real-World Use of Immunotherapy for Hepatocellular Carcinoma
por: Sara, Amir, et al.
Publicado: (2023)